Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of FLUAD-H5N1 Influenza Vaccine in Adults and Elderly
2008-000895-25Phase 2Completed
- Sponsor
- Novartis
- Start
- May 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Audenz in influenza, sponsored by Novartis. Primary endpoint: Hemagglutination inhibition (HI) antibody titers at Day 43. Started May 2008; status: completed.
02
Drugs
Audenz
03
Conditions
influenza
Beyond the preview
Go deeper on 2008-000895-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000895-25.